Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung Cancer to PD-L1 Blockade-Reply. Ricciuti B, Wang X, Awad MM. JAMA Oncol 2023 Feb 2. doi: 10.1001/jamaoncol.2022.7589.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ricciuti B, Wang X, Awad MM. Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung Cancer to PD-L1 Blockade-Reply. JAMA Oncol 2023 Feb 2. doi: 10.1001/jamaoncol.2022.7589.
PMID: 36729462